Evidence map›Paper›PMID 33580225›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases.

Shilpa Nadimpalli Kobren, Dustin Baldridge, Matt Velinder, Joel B Krier, Kimberly LeBlanc, Cecilia Esteves, Barbara N Pusey, Stephan Züchner, Elizabeth Blue, Hane Lee and 13 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Arriving at a diagnosis: Effective strategies used by the Undiagnosed Diseases Network.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Considerations for reporting variants in novel candidate genes identified during clinical genomic testing.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  11. Article
  12. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  13. VarPPUD: Variant post prioritization developed for undiagnosed genetic disorders.medRxiv : the preprint server for health sciences · 2024
    Article
  14. Article
  15. Dual diagnosis ofRare (Amsterdam, Netherlands) · 2024
    Article
  16. Review
  17. Article
  18. In vivo versus in silico assessment of potentially pathogenic missense variants in human reproductive genes.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Genomic medicine for liver disease.Hepatology (Baltimore, Md.) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 1 country.

Shilpa Nadimpalli KobrenDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Dustin BaldridgeDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Matt VelinderCenter for Genomic Discovery, University of Utah, Salt Lake City, UT, USA.
Joel B KrierDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kimberly LeBlancDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Cecilia EstevesDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Barbara N PuseyNational Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH), Bethesda, MD, USA.
Stephan ZüchnerDepartment of Human Genetics and Hussman Institute for Human Genomics, University of Miami Health System, Miami, FL, USA.
Elizabeth BlueDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA, USA.
Hane LeeDepartment of Human Genetics, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Alden HuangDepartment of Human Genetics, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Lisa BastaracheDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Anna BicanDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Joy CoganDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Shruti MarwahaStanford Center for Undiagnosed Diseases, Stanford, CA, USA.
Anna AlkelaiInstitute for Genomic Medicine, Columbia University Medical Center, New York City, NY, USA.
David R MurdockDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Pengfei LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Daniel J WegnerDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Alexander J PaulMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
Undiagnosed Diseases Network
Shamil R SunyaevDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Isaac S KohaneDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. isaac_kohane@hms.harvard.edu.ORCID http://orcid.org/0000-0003-2192-5160
National Institutes of Health · USSeattle Children's Hospital · USBaylor College of Medicine · USUniversity of California, Los Angeles · USStanford University · USBrigham and Women's Hospital · USUniversity of Miami · USUniversity of Utah · USVanderbilt University · USHarvard University · USDuke University · USWashington University in St. Louis · USChildren's Hospital of Philadelphia · USMayo Clinic in Florida · USUniversity of Alabama · USColumbia University · USUniversity of Oregon · USVanderbilt University Medical Center · USBaylor Genetics · USColumbia University Irving Medical Center · US

Funding

Coordinating Center for the Undiagnosed Diseases NetworkU01HG007530 · NHGRI · HARVARD MEDICAL SCHOOL · PI KOHANE, ISAAC S. · 2014 to 2022
$30.2M
Vanderbilt Center for Undiagnosed Diseases (VCUD) - BiorepositoryU01HG007674 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COGAN, JOY D, HAMID, RIZWAN · 2014 to 2022
$13.7M
An integrated and diverse genomic medicine program for undiagnosed diseasesU01HG007672 · NHGRI · DUKE UNIVERSITY · PI SHASHI, VANDANA · 2014 to 2022
$13.4M
Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
Clinical Sequencing Core Facility for the Undiagnosed Diseases Network (UDN)U01HG007942 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI ENG, CHRISTINE · 2014 to 2021
$10.2M
UCLA clinical site for the investigation of undiagnosed disordersU01HG007703 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARTINEZ-AGOSTO, JULIAN, NELSON, STANLEY F. · 2014 to 2022
$10.1M
What comes next? Engaging stakeholders in governance of participant data and relationships during the sunset of large genomic medicine research initiativesU01HG010218 · NHGRI · STANFORD UNIVERSITY · PI ASHLEY, EUAN A, BERNSTEIN, JONATHAN ADAM · 2018 to 2022
$6.3M
Pacific Northwest Undiagnosed Diseases Network Clinical SiteU01HG010233 · NHGRI · UNIVERSITY OF WASHINGTON · PI DIPPLE, KATRINA M, JARVIK, GAIL PAIRITZ · 2018 to 2022
$5.4M
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE UNDIAGNOSED DISEASES NETWORK CLINICAL SITEU01HG010215 · NHGRI · WASHINGTON UNIVERSITY · PI DICKSON, PATRICIA I · 2018 to 2022
$3.4M
The Undiagnosed Diseases Network Clinical Site of MiamiU01NS134353 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MUSTAFA TEKIN, Stephan Zuchner · 2023 to 2026
$3.1M
Intermountain West Clinical Site for the Undiagnosed Disease Network (UDN) Phase 2 SupplementU01HG010217 · NHGRI · UNIVERSITY OF UTAH · PI BOTTO, LORENZO DAVIDE · 2018 to 2022
$2.8M
Exploring minorities The Undiagnosed Diseases Network Clinical Site of MiamiU01HG010230 · NHGRI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TEKIN, MUSTAFA, ZUCHNER, STEPHAN · 2018 to 2021
$2.6M
NHGRI NIH HHS U01 HG007530NHGRI NIH HHS U01 HG007672NHGRI NIH HHS U01 HG007674NHGRI NIH HHS U01 HG007690NHGRI NIH HHS U01 HG007703NHGRI NIH HHS U01 HG007942NHGRI NIH HHS U01 HG010215NHGRI NIH HHS U01 HG010217NHGRI NIH HHS U01 HG010218NHGRI NIH HHS U01 HG010230NHGRI NIH HHS U01 HG010233NINDS NIH HHS U01 NS134353
6 · The paper itself

Abstract

purposeGenomic sequencing has become an increasingly powerful and relevant tool to be leveraged for the discovery of genetic aberrations underlying rare, Mendelian conditions. Although the computational tools incorporated into diagnostic workflows for this task are continually evolving and improving, we nevertheless sought to investigate commonalities across sequencing processing workflows to reveal consensus and standard practice tools and highlight exploratory analyses where technical and theoretical method improvements would be most impactful.

methodsWe collected details regarding the computational approaches used by a genetic testing laboratory and 11 clinical research sites in the United States participating in the Undiagnosed Diseases Network via meetings with bioinformaticians, online survey forms, and analyses of internal protocols.

resultsWe found that tools for processing genomic sequencing data can be grouped into four distinct categories. Whereas well-established practices exist for initial variant calling and quality control steps, there is substantial divergence across sites in later stages for variant prioritization and multimodal data integration, demonstrating a diversity of approaches for solving the most mysterious undiagnosed cases.

conclusionThe largest differences across diagnostic workflows suggest that advances in structural variant detection, noncoding variant interpretation, and integration of additional biomedical data may be especially promising for solving chronically undiagnosed cases.

Indexed as

GenomicsUndiagnosed DiseasesComputational BiologyGenetic TestingGenomeHumansSoftwareWorkflow

Identifiers

PMID33580225
PMCPMC8187147
OpenAlexW3128055903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.